Compounds > 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole
Page last updated: 2024-08-26

1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole and Adrenal Cancer

1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole has been researched along with Adrenal Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fasolato, C; Pizzo, P; Pozzan, T1

Other Studies

1 other study(ies) available for 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole and Adrenal Cancer

ArticleYear
Receptor-mediated calcium influx in PC12 cells. ATP and bradykinin activate two independent pathways.
    The Journal of biological chemistry, 1990, Nov-25, Volume: 265, Issue:33

    Topics: Adenosine Triphosphate; Adrenal Gland Neoplasms; Animals; Biological Transport, Active; Bradykinin; Calcium; Cell Line; Cell Membrane; Egtazic Acid; Imidazoles; Kinetics; Membrane Potentials; Pheochromocytoma; Platelet Aggregation Inhibitors; Rats

1990